AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Ubeaud, G Schiller, CD Hurbin, F Jaeck, D Coassolo, P
Citation: G. Ubeaud et al., Comparison of the stability of some major cytochrome P450 and conjugation reactions in rat, dog and human hepatocyte monolayers, EUR J DRUG, 26(1-2), 2001, pp. 37-45

Authors: Zuegge, J Schneider, G Coassolo, P Lave, T
Citation: J. Zuegge et al., Prediction of hepatic metabolic clearance - Comparison and assessment of prediction models, CLIN PHARMA, 40(7), 2001, pp. 553-563

Authors: Binda, D Nicod, L Viollon-Abadie, C Rodriguez, S Berthalot, A Coassolo, P Richert, L
Citation: D. Binda et al., Strain difference (WKY, SPRD) in the hepatic antioxidant status in rat andeffect of hypertension (SHR, DOCA). Ex vivo and in vitro data, MOL C BIOCH, 218(1-2), 2001, pp. 139-146

Authors: Ubeaud, G Schiller, CD Hurbin, F Jaeck, D Coassolo, P
Citation: G. Ubeaud et al., Estimation of flavin-containing monooxygenase activity in intact hepatocyte monolayers of rat, hamster, rabbit, dog and human by using N-oxidation ofbenzydamine, EUR J PH SC, 8(4), 1999, pp. 255-260

Authors: Lave, T Coassolo, P Reigner, B
Citation: T. Lave et al., Prediction of hepatic metabolic clearance based on interspecies allometricscaling techniques and in vitro in vivo correlations, CLIN PHARMA, 36(3), 1999, pp. 211-231

Authors: Clozel, M Ramuz, H Clozel, JP Breu, V Hess, P Loffler, BM Coassolo, P Roux, S
Citation: M. Clozel et al., Pharmacology of tezosentan, new endothelin receptor antagonist designed for parenteral use, J PHARM EXP, 290(2), 1999, pp. 840-846

Authors: Schneider, G Coassolo, P Lave, T
Citation: G. Schneider et al., Combining in vitro and in vivo pharmacokinetic data for prediction of hepatic drug clearance in humans by artificial neural networks and multivariatestatistical techniques, J MED CHEM, 42(25), 1999, pp. 5072-5076
Risultati: 1-7 |